Ghrelin, an endogenous ligand of the GH (growth hormone) secretagogue receptor, influences many metabolic processes including GH secretion, food intake, energy balance, insulin secretion and adipogenesis. Although ghrelin exhibits a variety of biological functions, the mechanism by which ghrelin expression is regulated is unknown. Ghrelin is expressed in the gastrointestinal tract, predominantly in the stomach, as is KLF4 (Krüppel-like factor 4). Therefore we investigated whether ghrelin expression is associated with KLF4, and found that the tissue distribution of ghrelin corresponded with that of KLF4. Furthermore, treatment with butyrate, an inducer of KLF4 expression, stimulated ghrelin expression, and fasting, which induces ghrelin expression, also increased KLF4 expression, suggesting that ghrelin expression is associated with KLF4. Then, we investigated the effects of KLF4 on the human ghrelinpromoter activity and identified a KLF4-responsive region in the promoter. KLF4 expression specifically stimulated human ghrelin-promoter activity in a dose-dependent manner in human gastric-cancer AGS cells. However, this effect was not seen in response to a mutant KLF4 construct. Transfection studies using mutant constructs containing 5 -deletions in the human ghrelin promoter revealed that the KLF4-responsive element is located between − 1228 and − 1105. Electrophoretic mobility shift assays using oligonucleotides containing − 1165/− 1146 revealed the binding of KLF4 to the human ghrelin promoter. Finally, deletion of the − 1165/− 1146 region abrogated KLF4-induced transactivation of the ghrelin promoter. Collectively, these results indicate that KLF4 positively regulates human ghrelin expression via binding to a KLF-responsive region in the promoter.
INTRODUCTION
The gastrointestinal tract plays a crucial role in homoeostasis through its effects on the digestion, absorption and assimilation of ingested nutrients. Ghrelin, an orexigenic hormone composed of 28 amino acids that is secreted from the stomach during fasting, stimulates the release of GH (growth hormone) from the pituitary gland and regulates both food intake and energy balance [1] [2] [3] . The effect of ghrelin on appetite is mediated by the hypothalamus through the stimulation of NPY (neuropeptide Y), AGRP (Agoutirelated protein) and orexin release [4, 5] ; the inhibition of α-MSH (α melanocyte-stimulating hormone) and CART (cocaine-and amphetamine-regulated transcript) release; and the activation of GHS-R (GH secretagogue receptor) on vagal afferents in the stomach [6] . The effects of ghrelin on body weight include a reduction in energy expenditure and the promotion of adiposity [7] . Ghrelin also has numerous peripheral effects, including direct effects on exocrine and endocrine pancreatic functions, adipogenesis, lipid metabolism, carbohydrate metabolism, the cardiovascular system, gastric function, stomach motility and sleep [8] .
Ghrelin mRNA is expressed predominantly in the stomach, but low levels have been reported in the bowel, pituitary gland, kidney, lung, placenta, testis, pancreas, leucocytes and hypothalamus; moreover, trace amounts have been detected in the adrenal gland, adipocytes, gall bladder, skeletal muscle, skin, spleen, liver, ovary and prostate [9] . The expression of ghrelin increases under conditions of negative energy balance, such as starvation, cachexia and anorexia nervosa, but decreases under conditions of positive energy balance, such as feeding, hyperglycaemia and obesity [10] . Somatostatin and its analogues, as well as urocortin-1, a potent anorexigenic peptide, also suppress ghrelin expression [11, 12] . GH deficiency decreases the mRNA expression of ghrelin in the stomach and plasma ghrelin levels [13] , suggesting that GH from the pituitary regulates ghrelin production in the stomach. Clinical data show that plasma ghrelin is associated with obesity [14] . In Prader-Willi syndrome, which is the most common form of human syndromic obesity, plasma ghrelin is increased 3-to 4-fold [15] . In contrast, ghrelin levels are reduced or normal in patients with other genetic obesities, such as leptin-receptor mutations or melanocortin-4-receptor mutations [16, 17] .
The human ghrelin promoter has been isolated and characterized [18] , and two transcriptional initiation sites are known to exist within human ghrelin: one at − 80 and the other at − 555. Both transcripts are expressed at equal levels in the human stomach, whereas the longer transcript is expressed primarily in the thyroid medullary carcinoma TT cell line. The basic helixloop-helix transcription factors USF1 (upstream transcription factor 1) and USF2 specifically bind to E-boxes in the human ghrelin promoter as a heterodimer, and may play a role in the regulation of human ghrelin expression; however, the regulatory mechanism of ghrelin transcription is unknown.
KLF4 (Krüppel-like factor 4), also known as GKLF (gutenriched Krüppel-like factor), is a zinc-finger-containing transcription factor that binds to GC-rich DNA with a consensus binding sequence of CACCC [19, 20] . KLF4 is a member of the KLF family, which contains at least 16 members that are highly expressed in the gastrointestinal tract (especially the colon and small intestine) and other epithelial tissues, including skin, lung, testis and thymus [21] . KLF4 contains both transcriptional activation and repression domains, and is known to activate and repress gene expression [22] . Analyses of KLF4 target genes have shown that KLF4 regulates cell growth and differentiation in these tissues by promoting the down-regulation of the ODC (ornithine decarboxylase gene) promoter [23] and the up-regulation of several keratin-encoding genes [24, 25] . In addition, KLF4 is required for p53-mediated G 2 /M cell-cycle arrest following DNA damage [26] and the terminal differentiation of goblet cells in the colon [27] . KLF4 is also required for normal gastric epithelial proliferation and differentiation.
Among the major organs, the gastrointestinal tract shows the highest level of KLF4 expression; thus we investigated whether KLF4 contributes to ghrelin expression in the stomach. We found that KLF4 increases ghrelin transcription in the stomach, which may play an important role in the tissue-specific or fastingmediated expression of ghrelin. Silence-selected pre-designed and validated siRNA (small interfering RNA) targeting KLF4 (sense strand, 5 -GAAAUUCG-CCCGCUCAGAU-3 ; antisense strand, 5 -AUCUGAGCGGGC-GAAUUUC-3 ) was obtained from Bioneer Corp.
Transient transfection and luciferase assay
HEK-293 cells grown in six-well plates were transiently transfected with human ghrelin promoters and KLF4 expression plasmid using Lipofectamine TM reagent (Invitrogen) according to the manufacturer's instructions. At 48 h post-transfection, the cells were lysed in reporter lysis buffer (Promega) and luciferase activity was measured using a Luciferase Assay System (Promega). To normalize the transfection efficiency, a pCMV-β-gal vector (Promega) was included in each transfection as an internal-control plasmid and luciferase activity was normalized to β-galactosidase activity in each transfection.
EMSA (electrophoretic mobility shift assay)
Probes were annealed with the following oligomers: the sense oligomers 5 -CTGCTGGAGGGAGGCAAGGCA-3 (for site 1), 5 -TGAAAAAACGCCAGGCCAGGC-3 (for site 2) and 5 -GTCATGTCACACCTGGCAGAAAT-3 (for site 3); and the antisense oligomers 5 -TGCCTTGCCTCCCTCCAGCAG-3 (for site 1), 5 -GCCTGGCCTGGCGTTTTTTCA-3 (for site 2), and 5 -ATTTCTGCCAGGTGTGACATGAC-3 (for site 3). Each set of oligomers was mixed with 5× sequencing buffer (200 mM Tris/HCl, pH 7.5, 100 mM MgCl 2 and 250 mM NaCl) and then heated at 99
• C for 5 min. The oligomers were cooled naturally and loaded on to a special agarose gel [3:1 (w/w) NuSieve agar/agar (Promega)] for elution using a MERmaid Kit (Qbiogene). The probes were labelled with γ -[ 32 P]ATP (PerkinElmer) and purified using a QIAquick Nucleotide Removal Kit (Qiagen). EMSAs were performed as previously described [28] . For competition experiments or antibody-supershift assays, nuclear extracts (5 μg) were incubated with unlabelled competitors or antibodies for 30 min at room temperature (25 • C), followed by incubation with radiolabelled probe for 30 min at room temperature, and then loaded on to 5 % native polyacrylamide gels for separation by SDS/PAGE. The dried gels were exposed at − 70
• C for more than 24 h. Antibodies for KLF4 and ATF3 (activating transcription factor 3) were purchased from Santa Cruz Biotechnology.
Preparation of nuclear protein
Nuclear extracts were prepared from AGS cells as described previously [29] . The plates were scraped and centrifuged, then mixed with 1 ml of cold Buffer A [25 mM Hepes, 
RT-PCR (reverse transcription-PCR)
Total RNA was extracted using QIAzol Lysis Reagent (Qiagen). The mRNA in the samples was reverse-transcribed using a Superscript TM II First Strand cDNA Synthesis Kit (Invitrogen). The resulting cDNA was amplified by PCR using the primer pairs ghrelin-F (5 -ATCTGCAGTTTGCTGCTACT-3 ) and ghrelin-R (5 -GATACTGAGCTCCTGACAGC-3 ) and KLF4-F (5 -CAC-AAAGAGTTCCCATCTCAA-3 ) and KLF4-R (5 -CTTCAT-GTGTAAGGCGAGGT-3 ). The housekeeping gene β-actin was amplified using the sense primer 5 -GTCGTACCACTGG-CATTGTG-3 and the antisense primer 5 -CTCTCAGCTGT-GGTGGTGAA-3 . RT-PCR blots were quantified using Tina 2.0 software (Raytest) and normalized to β-actin. 
ICR) were obtained from the Experimental Animal Resource
Laboratory of the KFDA. After 48 h of fasting and 24 h of refeeding, the mice were killed, and their stomachs, livers, kidneys, muscles and large intestines were collected and stored at − 80
• C for mRNA isolation.
Statistical analysis
All experiments were performed at least three times. The results were expressed as the mean + − S.E.M. Statistical analysis was performed using Student's t test. (The results in Figure 1A were analysed using Duncan's multiple-range test.) The results were considered statistically significant at P < 0.05.
RESULTS

Ghrelin expression is correlated with KLF4 expression
To analyse the correlation between ghrelin and KLF4 expression, we examined the expression patterns of ghrelin and KLF4 in various tissues (e.g. stomach, liver, kidney, muscle and large intestine) from 8-week-old male ICR mice by RT-PCR. As shown in Figure 1 (A), ghrelin expression was highest in the stomach and large intestine, which is consistent with previous results ( Figure 1A, left) . In accordance with ghrelin, KLF4 displayed a similar expression pattern ( Figure 1A, right) . Butyrate, the most abundant short-chain fatty acid in the gastrointestinal tract, was previously reported to stimulate KLF4 expression [30] . Therefore, to determine whether butyrate also stimulates ghrelin expression through an increase in KLF4 expression, we treated AGS cells with butyrate for 12 h and analysed ghrelin expression. Butyrate treatment increased ghrelin expression ( Figure 1B , left), concomitant with the induction of KLF4 expression in AGS cells ( Figure 1B, right) . To confirm the observation that KLF4 expression induced by butyrate leads to increased ghrelin expression, we inhibited KLF4 using siRNA and determined the effects of butyrate on ghrelin expression. KLF4 siRNA effectively inhibited expression of KLF4 ( Figure 1C, left) , and suppression of KLF4 by siRNA blocked the butyrate-induced Figure 1C, right) . Together, these results suggest that ghrelin expression is associated with KLF4 expression. Next, we examined how KLF4 overexpression affects the transcription of ghrelin in AGS cells using a pcDNA-3.1-KLF4 construct. As shown in Figure 1(D) , overexpression of KLF4 led to an increase in the mRNA expression of ghrelin in proportion to the level of KLF4 protein.
KLF4 increases the activity of the human ghrelin promoter
Two transcripts may be produced from the human ghrelin promoter: a long transcript (transcript A) and a short transcript (transcript B). The transcription-initiation sites are located at − 80 and − 555 respectively. To investigate the effects of KLF4 on the expression of human ghrelin, we isolated the 5 -flanking regions of transcripts A and B respectively. Both the − 1997/− 33 upstream region of transcript A and the − 1997/− 495 upstream region of transcript B were isolated by PCR and inserted into pGL3-Basic to create 1997A and 1997B (Figure 2A) . The constructs were then transiently transfected into HEK-293 cells with a KLF4 expression vector and luciferase activity was examined. As shown in Figure 2 (B), HEK-293 cells transfected with KLF4 showed a dose-dependent increase in ghrelin-promoter activity. However, the increase was significantly inhibited by the co-transfection of a mutant KLF4 construct containing only the zinc-finger DNAbinding domain without the transcriptional regulatory domain or nuclear localization sequence ( Figure 2C ). Furthermore, we examined the effects of other KLF transcription factors on ghrelin expression in HEK-293 cells. As shown in Figure 2 (D), although KLF2 and KLF5 increase the ghrelin promoter activity, KLF4 increased the promoter activity greatly compared with the increase observed using KLF2 or KLF5. These results indicate that KLF4 specifically stimulates the transcription of human ghrelin.
Identification of the KLF4-responsive region
To define the KLF4-responsive region in the ghrelin promoter, we introduced 5 serial deletions into the ghrelin promoter and transfected the resulting constructs into HEK-293 cells. As shown in Figure 3 , the deletion of nucleotides − 1997 to − 1228 did not affect the transactivation of the ghrelin promoter by KLF4. However, increasing the deletion to − 778 resulted in a nearly complete loss of induction by KLF4 (Figure 3, upper) . To pinpoint the KLF4-responsive region, a − 1105 ghrelin promoter was constructed. The promoter showed almost complete resistance to induction by KLF4 (Figure 3, lower) , suggesting that the KLF4-responsive region is located between nucleotides − 1228 and − 1105. A computer-assisted search of the 120-bp region using TFSEARCH (http://www.cbrc.jp/research/db/TFSEARCH.html) revealed three putative KLF-binding sites, designated sites 1, 2 and 3 ( Figure 4A ). To determine whether KLF4 is capable of binding to these putative binding sites, we performed EMSAs using three labelled oligonucleotide probes covering each putative binding site and AGS-cell nuclear extracts. As shown in Figure 4 (B), the probe including site 3 (− 1165/− 1146) showed binding to the extracts. Complex formation was competitively inhibited by an unlabelled homologous competitor but not by a non-homologous competitor ( Figure 4C ), suggesting that the binding was specific. To demonstrate the binding of site 3 by KLF4, a supershift assay was performed using an anti-KLF4 antibody. As shown in Figure 4(D) , the antibody specifically eliminated the upper band of the complex, whereas a non-specific antibody had no effect, indicating that KLF4 specifically binds to site 3. Together, these results demonstrate that KLF4 interacts directly with the ghrelin promoter.
To verify that site 3 is crucial for the KLF4-mediated transactivation of the ghrelin promoter, we deleted site 3 within the context of the − 1997 promoter ( Figure 5A ) and transfected the resulting construct into HEK-293 cells. Transfection with the deletion mutant significantly abolished the induction of the ghrelin promoter by KLF4 ( Figure 5B ), indicating that site 3 is crucial for the transactivation of ghrelin by KLF4. However, the activity of the mutant promoter is still increased by KLF4 overexpression, although the increase is lower compared with the wild-type promoter, suggesting that alternative KLF4-binding sites unidentified in this study may be present within the promoter.
KLF4 increases the expression of ghrelin during fasting in co-ordination with CREB (cAMP-response-element-binding protein)
As ghrelin expression is elevated during fasting, we analysed the level of KLF4 transcription in the stomachs of fasted rats to determine whether KLF4 plays a role in the stimulation of ghrelin expression under fasting conditions. As shown in Figure 6 (A), 48 h of fasting increased the transcription of KLF4 (Figure 6A , right) in parallel with an increase in ghrelin expression ( Figure 6A , left), suggesting that fasting-induced ghrelin expression may be promoted by KLF4. CREB is a transcription factor responsible for the transactivation of various genes under fasting conditions. The increased expression of KLF4 during fasting raised the possibility that KLF4 and CREB may function in a co-ordinated manner to induce ghrelin expression. To assess this possibility, we performed a co-transfection study using KLF4 and CREB expression vectors. Transfection with 0.2 μg of KLF4 or 1 μg of CREB stimulated the activity of wild-type − 1997 bp promoter 2-and 8-fold respectively, whereas co-transfection with KLF4 and CREB resulted in the synergistic activation of the promoter (approx. 16-fold; Figure 6B , left). However, even though CREB still increased the activity of the mutant promoter, synergistic activation was not observed on the mutant promoter ( Figure 6B , right). Thus KLF4 increases the expression of ghrelin during fasting via a coordinated effort with CREB.
DISCUSSION
Ghrelin is produced mainly in the stomach, where it plays a regulatory role in a variety of metabolic processes; however, the mechanism underlying the regulation of ghrelin expression is poorly understood. The regulation of ghrelin and its effects may occur at several levels: transcription and translation, posttranslational modification, and changes in the rate of secretion of ghrelin from cells in the stomach, hypothalamus and other sites. Fasting increases the expression of ghrelin mRNA in the stomach, but not in the pituitary or hypothalamus [4] . Hyperglycaemia suppresses ghrelin levels in humans [31] , whereas a high-fat diet increases stomach-ghrelin expression in mice [32] . In humans, a carbohydrate-rich diet causes a larger drop in ghrelin levels than a high-fat diet [33] . Insulin and leptin have been shown to increase ghrelin expression [34] , but both molecules have also been shown to decrease gastric-ghrelin expression [31, 35] . GHreleasing hormone (GHRH) up-regulates ghrelin expression in rat pituitary [36] . Thyroid-hormone deficiency increases the level of circulating ghrelin as well as the transcription of gastric ghrelin [13] . PP (pancreatic polypeptide) significantly inhibits the mRNA expression of gastric ghrelin in rats deprived of food for 24 h [37] , but the transcription factors responsible for the regulation of ghrelin expression are unknown.
KLFs are highly related zinc-finger proteins that take part in almost all facets of cellular function, including cellular proliferation, apoptosis, differentiation and neoplastic transformation, by regulating the expression of numerous genes with GC-rich promoters as activators or repressors. Most members of this family (which contains at least 16 proteins) have been identified in mammals. KLFs are usually expressed in a tissue-selective manner [38] . The tissue distribution of KLF4 is enriched for the gastrointestinal tract, hence the name GKLF. Therefore, in the current study, we investigated the regulation of human ghrelin expression by KLF4 because ghrelin and KLF4 display similar tissue distributions. KLF4 efficiently stimulated human ghrelin-promoter activity, but that stimulation was blocked by a mutant KLF4 construct. Furthermore, the transactivation of ghrelin by KLF4 was specific; none of the other KLFs used in this study stimulated promoter activity, demonstrating that KLF4 specifically stimulates human ghrelin expression. The stimulation of ghrelin expression occurred as a result of the binding of KLF4 to the − 1165/− 1146 region of the human ghrelin promoter. The binding of KLF4 to the ghrelin promoter was revealed by an EMSA; a complex was formed with the − 1165/− 1146 nucleotide region in nuclear extracts from AGS cells. The binding was specific for KLF4 because an anti-KLF4 antibody specifically eliminated the upper band of the complex. When the biological importance of the KLF4-binding region was investigated using a mutant lacking the KLF4-binding site, the deleted mutant showed no stimulation of the ghrelin promoter by KLF4, indicating that the KLF4-binding site between − 1165 and − 1146 is crucial for the transactivation of ghrelin by KLF4. KLF4 functions in the regulation of cellular growth and differentiation in various target tissues via the activation or repression of associated genes, including the down-regulation of ODC-promoter activity [23] and the up-regulation of several keratin-encoding genes [39] . In addition, KLF4 is involved in the p53-mediated G 2 /M cell-cycle arrest following DNA damage and in the terminal differentiation of goblet cells in the colon [40] . KLF4 is also associated with normal gastric epithelial proliferation and differentiation [41] . Our finding that KLF4 activates the expression of ghrelin, an appetite hormone, strongly suggests that KLF4 mediates metabolic functions through the regulation of ghrelin expression. The plasma ghrelin level was shown to increase during fasting and decrease following refeeding in the present study and in previous studies [42] . However, the factors regulating ghrelin expression have not been clarified. We found that fasting increases KLF4 expression, which synergistically stimulates the CREBmediated transactivation of ghrelin. CREB is a transcription factor known to activate diverse genes under fasting conditions. However, cAMP-response-element is not present within the − 1997 upstream region of the human ghrelin gene, suggesting that CREB may stimulate ghrelin expression under fasting conditions indirectly through interaction with a cell-specific transcription factor. Therefore, KLF4 is a candidate transcription factor that stimulates ghrelin expression during fasting with the interaction of CREB, because the combination of KLF4 and CREB resulted in synergistic activation of the ghrelin promoter as well as KLF4-specific activation of ghrelin gene expression. The manner in which KLF4 regulates gene expression has been analysed in several studies. KLF4 inhibits the activity of the cytochrome P450 (CYP1A1) promoter via its ability to compete physically with Sp1, a strong activator of the CYP1A1 promoter [43] . In contrast, other studies have shown that KLF4 activates transcription on its own or in conjunction with other KLFs [44, 45] . KLF4 is, therefore, a pleiotropic transcription factor with a context-dependent transcription-activating or -suppressing activity. In addition, KLF4 physically interacts with p300/CBP (CREB-binding protein) transcriptional co-activators, and this interaction is necessary for the transactivating ability of KLF4 [46] .
In summary, the present study demonstrates a clear relationship between ghrelin expression and KLF4. KLF4 positively regulates human ghrelin expression via binding to the promoter. These findings may help to clarify the regulation of human ghrelin expression.
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